

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of activin receptor signaling pathway (GO:0032926) | 7.44143983 |
| 2 | regulation of mesoderm development (GO:2000380) | 6.39319505 |
| 3 | nodal signaling pathway (GO:0038092) | 6.25835526 |
| 4 | sequestering of extracellular ligand from receptor (GO:0035581) | 5.83578669 |
| 5 | anterior/posterior axis specification, embryo (GO:0008595) | 5.79342879 |
| 6 | cell migration involved in gastrulation (GO:0042074) | 5.71323824 |
| 7 | regulation of activin receptor signaling pathway (GO:0032925) | 5.32239900 |
| 8 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.96642597 |
| 9 | signal transduction involved in regulation of gene expression (GO:0023019) | 4.84881244 |
| 10 | glutamate receptor signaling pathway (GO:0007215) | 4.64676665 |
| 11 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 4.62032858 |
| 12 | vocalization behavior (GO:0071625) | 4.56949918 |
| 13 | L-ascorbic acid metabolic process (GO:0019852) | 4.55263083 |
| 14 | locomotory exploration behavior (GO:0035641) | 4.41011702 |
| 15 | kidney morphogenesis (GO:0060993) | 4.40677391 |
| 16 | protein localization to synapse (GO:0035418) | 4.32136838 |
| 17 | neuron recognition (GO:0008038) | 4.32104209 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.17721127 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.15697774 |
| 20 | axonal fasciculation (GO:0007413) | 4.12026898 |
| 21 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.04987796 |
| 22 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.98543532 |
| 23 | exploration behavior (GO:0035640) | 3.95488852 |
| 24 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.95317819 |
| 25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.92759704 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 3.92590078 |
| 27 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.87545293 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.87476931 |
| 29 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.87141228 |
| 30 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.83783231 |
| 31 | anterior/posterior axis specification (GO:0009948) | 3.82939607 |
| 32 | synaptic transmission, glutamatergic (GO:0035249) | 3.81258906 |
| 33 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 3.80882867 |
| 34 | embryonic pattern specification (GO:0009880) | 3.79707561 |
| 35 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.78683995 |
| 36 | long-term synaptic potentiation (GO:0060291) | 3.77474034 |
| 37 | synaptic vesicle exocytosis (GO:0016079) | 3.70318843 |
| 38 | response to histamine (GO:0034776) | 3.64651634 |
| 39 | glomerular visceral epithelial cell development (GO:0072015) | 3.64293149 |
| 40 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.62496727 |
| 41 | lactate metabolic process (GO:0006089) | 3.61681683 |
| 42 | embryonic camera-type eye development (GO:0031076) | 3.59795363 |
| 43 | platelet dense granule organization (GO:0060155) | 3.59201055 |
| 44 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.59029523 |
| 45 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.54814325 |
| 46 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.54079498 |
| 47 | genitalia morphogenesis (GO:0035112) | 3.53148131 |
| 48 | neuronal action potential propagation (GO:0019227) | 3.50617642 |
| 49 | L-serine transport (GO:0015825) | 3.49792210 |
| 50 | ephrin receptor signaling pathway (GO:0048013) | 3.47906586 |
| 51 | embryonic axis specification (GO:0000578) | 3.46456584 |
| 52 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.45689638 |
| 53 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.45514843 |
| 54 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.44846301 |
| 55 | extracellular negative regulation of signal transduction (GO:1900116) | 3.39468673 |
| 56 | extracellular regulation of signal transduction (GO:1900115) | 3.39468673 |
| 57 | startle response (GO:0001964) | 3.39462492 |
| 58 | behavioral defense response (GO:0002209) | 3.37703451 |
| 59 | behavioral fear response (GO:0001662) | 3.37703451 |
| 60 | glomerular epithelial cell development (GO:0072310) | 3.36929198 |
| 61 | regulation of timing of cell differentiation (GO:0048505) | 3.35913301 |
| 62 | regulation of cofactor metabolic process (GO:0051193) | 3.35829429 |
| 63 | regulation of coenzyme metabolic process (GO:0051196) | 3.35829429 |
| 64 | cellular response to BMP stimulus (GO:0071773) | 3.34052792 |
| 65 | response to BMP (GO:0071772) | 3.34052792 |
| 66 | dendritic spine organization (GO:0097061) | 3.33454737 |
| 67 | positive regulation of synapse maturation (GO:0090129) | 3.33325390 |
| 68 | somite rostral/caudal axis specification (GO:0032525) | 3.31092152 |
| 69 | regulation of postsynaptic membrane potential (GO:0060078) | 3.30698007 |
| 70 | female gonad development (GO:0008585) | 3.29646783 |
| 71 | inner ear receptor cell development (GO:0060119) | 3.27102865 |
| 72 | positive regulation of gastrulation (GO:2000543) | 3.26509596 |
| 73 | long-term memory (GO:0007616) | 3.25937454 |
| 74 | postsynaptic membrane organization (GO:0001941) | 3.25841461 |
| 75 | activin receptor signaling pathway (GO:0032924) | 3.25537544 |
| 76 | positive regulation of heart growth (GO:0060421) | 3.23995758 |
| 77 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.23719781 |
| 78 | regulation of synaptic plasticity (GO:0048167) | 3.23080616 |
| 79 | positive regulation of vesicle fusion (GO:0031340) | 3.19935357 |
| 80 | glutamate secretion (GO:0014047) | 3.19818959 |
| 81 | long term synaptic depression (GO:0060292) | 3.17845584 |
| 82 | primitive streak formation (GO:0090009) | 3.15446850 |
| 83 | dendritic spine morphogenesis (GO:0060997) | 3.15412960 |
| 84 | cochlea development (GO:0090102) | 3.14811291 |
| 85 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.14717213 |
| 86 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.14049890 |
| 87 | fear response (GO:0042596) | 3.12578588 |
| 88 | protein localization to cilium (GO:0061512) | 3.10667743 |
| 89 | presynaptic membrane assembly (GO:0097105) | 3.10015288 |
| 90 | transmission of nerve impulse (GO:0019226) | 3.08821882 |
| 91 | regulation of development, heterochronic (GO:0040034) | 3.08742634 |
| 92 | innervation (GO:0060384) | 3.08697496 |
| 93 | dopamine biosynthetic process (GO:0042416) | 3.08169952 |
| 94 | synaptic transmission, dopaminergic (GO:0001963) | 3.05137781 |
| 95 | protein autoprocessing (GO:0016540) | 3.01989691 |
| 96 | response to pheromone (GO:0019236) | 3.01123496 |
| 97 | otic vesicle formation (GO:0030916) | 2.98140429 |
| 98 | behavioral response to cocaine (GO:0048148) | 2.97746777 |
| 99 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.95475483 |
| 100 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.95153014 |
| 101 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.94767920 |
| 102 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.92627071 |
| 103 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.92401623 |
| 104 | synaptic vesicle endocytosis (GO:0048488) | 2.92052993 |
| 105 | keratinocyte development (GO:0003334) | 2.91953472 |
| 106 | regulation of sulfur metabolic process (GO:0042762) | 2.91805254 |
| 107 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.91715869 |
| 108 | regulation of gastrulation (GO:0010470) | 2.91150853 |
| 109 | SMAD protein signal transduction (GO:0060395) | 2.91045680 |
| 110 | regulation of vesicle fusion (GO:0031338) | 2.90817886 |
| 111 | Leydig cell differentiation (GO:0033327) | 2.90660146 |
| 112 | regulation of dendritic spine development (GO:0060998) | 2.90118465 |
| 113 | positive regulation of synapse assembly (GO:0051965) | 2.89776001 |
| 114 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.87322263 |
| 115 | presynaptic membrane organization (GO:0097090) | 2.86649190 |
| 116 | learning (GO:0007612) | 2.86470639 |
| 117 | regulation of synaptic vesicle transport (GO:1902803) | 2.86029371 |
| 118 | regulation of glutamate secretion (GO:0014048) | 2.85205343 |
| 119 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.84749457 |
| 120 | regulation of axon guidance (GO:1902667) | 2.84538848 |
| 121 | dorsal/ventral axis specification (GO:0009950) | 2.82577196 |
| 122 | glycosphingolipid biosynthetic process (GO:0006688) | 2.82468331 |
| 123 | regulation of neuron projection regeneration (GO:0070570) | 2.81398926 |
| 124 | regulation of axon regeneration (GO:0048679) | 2.81398926 |
| 125 | regulation of synapse maturation (GO:0090128) | 2.81326254 |
| 126 | regulation of female receptivity (GO:0045924) | 2.80758200 |
| 127 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.79992607 |
| 128 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.79590680 |
| 129 | glomerular basement membrane development (GO:0032836) | 2.79436082 |
| 130 | vesicle transport along microtubule (GO:0047496) | 2.79067083 |
| 131 | detection of calcium ion (GO:0005513) | 2.77305969 |
| 132 | serotonin receptor signaling pathway (GO:0007210) | 2.76747607 |
| 133 | gastrulation (GO:0007369) | 2.76389221 |
| 134 | positive regulation of cardiac muscle tissue development (GO:0055025) | 2.76036596 |
| 135 | serine transport (GO:0032329) | 2.74972634 |
| 136 | regulation of hexokinase activity (GO:1903299) | 2.74394301 |
| 137 | regulation of glucokinase activity (GO:0033131) | 2.74394301 |
| 138 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.73922587 |
| 139 | neuron remodeling (GO:0016322) | 2.73738971 |
| 140 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.72665388 |
| 141 | axis specification (GO:0009798) | 2.72398933 |
| 142 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.72298343 |
| 143 | regulation of synapse assembly (GO:0051963) | 2.72090350 |
| 144 | peptidyl-cysteine modification (GO:0018198) | 2.71613216 |
| 145 | regulation of cardiac muscle cell proliferation (GO:0060043) | 2.71508682 |
| 146 | chemosensory behavior (GO:0007635) | 2.70408056 |
| 147 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.68212714 |
| 148 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.68172978 |
| 149 | regulation of keratinocyte proliferation (GO:0010837) | 2.66710701 |
| 150 | proline transport (GO:0015824) | 2.66473585 |
| 151 | regulation of synapse organization (GO:0050807) | 2.65927930 |
| 152 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.65430008 |
| 153 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.64250046 |
| 154 | nonmotile primary cilium assembly (GO:0035058) | 2.63282866 |
| 155 | mitochondrial fission (GO:0000266) | 2.63141839 |
| 156 | cardiac right ventricle morphogenesis (GO:0003215) | 2.62546952 |
| 157 | layer formation in cerebral cortex (GO:0021819) | 2.57663140 |
| 158 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.57596573 |
| 159 | cellular potassium ion homeostasis (GO:0030007) | 2.57021576 |
| 160 | positive regulation of fibroblast migration (GO:0010763) | 2.56750420 |
| 161 | axon extension (GO:0048675) | 2.56363103 |
| 162 | female mating behavior (GO:0060180) | 2.56081164 |
| 163 | membrane depolarization (GO:0051899) | 2.56036475 |
| 164 | neurotransmitter secretion (GO:0007269) | 2.53800796 |
| 165 | estrogen metabolic process (GO:0008210) | 2.52923628 |
| 166 | memory (GO:0007613) | 2.52402524 |
| 167 | learning or memory (GO:0007611) | 2.52045705 |
| 168 | positive regulation of membrane potential (GO:0045838) | 2.51632034 |
| 169 | associative learning (GO:0008306) | 2.51428644 |
| 170 | atrial cardiac muscle cell action potential (GO:0086014) | 2.48831554 |
| 171 | digestive tract morphogenesis (GO:0048546) | 2.47998237 |
| 172 | limb bud formation (GO:0060174) | 2.47384448 |
| 173 | respiratory chain complex IV assembly (GO:0008535) | 2.46214139 |
| 174 | branched-chain amino acid catabolic process (GO:0009083) | 2.44374070 |
| 175 | signal peptide processing (GO:0006465) | 2.42941917 |
| 176 | phospholipid scrambling (GO:0017121) | 2.42298502 |
| 177 | glycerophospholipid catabolic process (GO:0046475) | 2.41470746 |
| 178 | multicellular organismal aging (GO:0010259) | 2.41077184 |
| 179 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.39240352 |
| 180 | ureteric bud development (GO:0001657) | 2.38394516 |
| 181 | regulation of tight junction assembly (GO:2000810) | 2.34464940 |
| 182 | cellular ketone body metabolic process (GO:0046950) | 2.34299282 |
| 183 | DNA double-strand break processing (GO:0000729) | 2.29897878 |
| 184 | regulation of neurotransmitter uptake (GO:0051580) | 2.29874133 |
| 185 | endoderm formation (GO:0001706) | 2.29147283 |
| 186 | regulation of stem cell maintenance (GO:2000036) | 2.27357544 |
| 187 | melanosome transport (GO:0032402) | 2.26988984 |
| 188 | establishment of melanosome localization (GO:0032401) | 2.26605850 |
| 189 | auditory receptor cell differentiation (GO:0042491) | 2.26148252 |
| 190 | embryonic foregut morphogenesis (GO:0048617) | 2.25830423 |
| 191 | DNA replication checkpoint (GO:0000076) | 2.24428218 |
| 192 | protein K6-linked ubiquitination (GO:0085020) | 2.23640846 |
| 193 | regulation of cardioblast differentiation (GO:0051890) | 2.23131852 |
| 194 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.21328093 |
| 195 | forebrain neuron differentiation (GO:0021879) | 2.20342049 |
| 196 | positive regulation of respiratory burst (GO:0060267) | 2.19233870 |
| 197 | S-adenosylmethionine metabolic process (GO:0046500) | 2.16764322 |
| 198 | regulation of cardiac muscle tissue growth (GO:0055021) | 2.15791657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.67246350 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.01096021 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.78075509 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.03237715 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.94295435 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93478286 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.73889780 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.72271840 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55967245 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55967245 |
| 11 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47308180 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46870226 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.45305651 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37924456 |
| 15 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.34640988 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.31421616 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24478649 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.08697424 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00535450 |
| 20 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.99956710 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98922964 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.96798393 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91492225 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.88644807 |
| 25 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83564743 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.83477112 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.82664200 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.82495516 |
| 29 | TP53_16413492_ChIP-PET_HCT116_Human | 1.79889764 |
| 30 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.79138795 |
| 31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78595269 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.78445274 |
| 33 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.77880003 |
| 34 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.76499654 |
| 35 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.75724046 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.75322425 |
| 37 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73012934 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71961464 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.70160527 |
| 40 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.69074323 |
| 41 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.68767152 |
| 42 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.68723847 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.66718236 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65993546 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63878822 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.63817495 |
| 47 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63555405 |
| 48 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.63046185 |
| 49 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.62543799 |
| 50 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.62543799 |
| 51 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.62543799 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.62321387 |
| 53 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.58425546 |
| 54 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.58346997 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56182881 |
| 56 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.53864920 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.53808673 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53391963 |
| 59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52882194 |
| 60 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52654772 |
| 61 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.52131999 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50958474 |
| 63 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50753985 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.47014667 |
| 65 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44249654 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43261355 |
| 67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.43114237 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.40098917 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40038067 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.39973018 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.39581765 |
| 72 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.38715611 |
| 73 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.32884397 |
| 74 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32262926 |
| 75 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32168052 |
| 76 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.31825657 |
| 77 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.31713068 |
| 78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29274130 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28735537 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27586118 |
| 81 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.26557908 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25969473 |
| 83 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25969473 |
| 84 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.25097666 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24822803 |
| 86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.24742454 |
| 87 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.24742454 |
| 88 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24352023 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23995655 |
| 90 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.23081746 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22224278 |
| 92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22167350 |
| 93 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19572119 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19145668 |
| 95 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.18969360 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18568099 |
| 97 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18435964 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18128968 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17628826 |
| 100 | JUN_21703547_ChIP-Seq_K562_Human | 1.17517384 |
| 101 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16674373 |
| 102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15994093 |
| 103 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15824854 |
| 104 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.15560292 |
| 105 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15536886 |
| 106 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15369855 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15160236 |
| 108 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14941012 |
| 109 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14867055 |
| 110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14604043 |
| 111 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.14181060 |
| 112 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14125930 |
| 113 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13775313 |
| 114 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13281094 |
| 115 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12962517 |
| 116 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12681795 |
| 117 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12402261 |
| 118 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.12262560 |
| 119 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12067535 |
| 120 | RXR_22108803_ChIP-Seq_LS180_Human | 1.12051472 |
| 121 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11898983 |
| 122 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11808075 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11462046 |
| 124 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11412460 |
| 125 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11280288 |
| 126 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11245176 |
| 127 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.11117087 |
| 128 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.11034973 |
| 129 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10460588 |
| 130 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.10439375 |
| 131 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10393265 |
| 132 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.09983960 |
| 133 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09587430 |
| 134 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09587430 |
| 135 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.09481409 |
| 136 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.09132316 |
| 137 | AR_19668381_ChIP-Seq_PC3_Human | 1.08825987 |
| 138 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.08218504 |
| 139 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07343371 |
| 140 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.05956072 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05763888 |
| 142 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05762774 |
| 143 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.05630659 |
| 144 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04193955 |
| 145 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.03990696 |
| 146 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.02794436 |
| 147 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01888918 |
| 148 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01356738 |
| 149 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.99712901 |
| 150 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97987429 |
| 151 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97508559 |
| 152 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97490577 |
| 153 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.97123996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.81939120 |
| 2 | MP0003890_abnormal_embryonic-extraembry | 5.66636115 |
| 3 | MP0003880_abnormal_central_pattern | 5.21207468 |
| 4 | MP0004133_heterotaxia | 3.91200981 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.64187572 |
| 6 | MP0008004_abnormal_stomach_pH | 3.47455069 |
| 7 | MP0009745_abnormal_behavioral_response | 3.13751126 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.12212936 |
| 9 | MP0004270_analgesia | 3.05194864 |
| 10 | MP0005623_abnormal_meninges_morphology | 2.61565899 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.57591398 |
| 12 | MP0002064_seizures | 2.55418862 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.47175459 |
| 14 | MP0010030_abnormal_orbit_morphology | 2.41174676 |
| 15 | MP0002736_abnormal_nociception_after | 2.32081603 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.23814586 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.21768151 |
| 18 | MP0001486_abnormal_startle_reflex | 2.14818108 |
| 19 | MP0001188_hyperpigmentation | 2.14323645 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.13811664 |
| 21 | MP0002272_abnormal_nervous_system | 2.12137104 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.07446767 |
| 23 | MP0009046_muscle_twitch | 1.96394737 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 1.95729906 |
| 25 | MP0002102_abnormal_ear_morphology | 1.93328204 |
| 26 | MP0000778_abnormal_nervous_system | 1.92006273 |
| 27 | MP0005379_endocrine/exocrine_gland_phen | 1.89640977 |
| 28 | MP0002163_abnormal_gland_morphology | 1.87787847 |
| 29 | MP0003329_amyloid_beta_deposits | 1.79830990 |
| 30 | MP0003195_calcinosis | 1.77034506 |
| 31 | MP0002734_abnormal_mechanical_nocicepti | 1.76095971 |
| 32 | MP0000372_irregular_coat_pigmentation | 1.74720712 |
| 33 | * MP0002184_abnormal_innervation | 1.74171637 |
| 34 | MP0003787_abnormal_imprinting | 1.69893715 |
| 35 | MP0000537_abnormal_urethra_morphology | 1.67692627 |
| 36 | MP0005248_abnormal_Harderian_gland | 1.61111024 |
| 37 | MP0002822_catalepsy | 1.60239953 |
| 38 | MP0006072_abnormal_retinal_apoptosis | 1.60100866 |
| 39 | MP0002938_white_spotting | 1.54397498 |
| 40 | MP0002067_abnormal_sensory_capabilities | 1.51422181 |
| 41 | MP0004272_abnormal_basement_membrane | 1.43281795 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.40765347 |
| 43 | MP0001529_abnormal_vocalization | 1.38285299 |
| 44 | MP0001970_abnormal_pain_threshold | 1.35582782 |
| 45 | MP0000647_abnormal_sebaceous_gland | 1.34928713 |
| 46 | MP0002234_abnormal_pharynx_morphology | 1.34438520 |
| 47 | MP0008995_early_reproductive_senescence | 1.32873042 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.31940791 |
| 49 | MP0006054_spinal_hemorrhage | 1.30048095 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.28847884 |
| 51 | MP0008872_abnormal_physiological_respon | 1.28558977 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.26765142 |
| 53 | MP0004484_altered_response_of | 1.25175912 |
| 54 | MP0003136_yellow_coat_color | 1.22480968 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.21642181 |
| 56 | MP0001177_atelectasis | 1.21393151 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.20113411 |
| 58 | MP0003137_abnormal_impulse_conducting | 1.18868529 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.17145461 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.16984680 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.16287286 |
| 62 | MP0006276_abnormal_autonomic_nervous | 1.14768648 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.14460973 |
| 64 | * MP0002882_abnormal_neuron_morphology | 1.13445376 |
| 65 | MP0004858_abnormal_nervous_system | 1.13045566 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.12825309 |
| 67 | MP0004147_increased_porphyrin_level | 1.11881230 |
| 68 | MP0005253_abnormal_eye_physiology | 1.11635871 |
| 69 | MP0001299_abnormal_eye_distance/ | 1.10337669 |
| 70 | MP0000462_abnormal_digestive_system | 1.09494956 |
| 71 | MP0004885_abnormal_endolymph | 1.08627544 |
| 72 | MP0003941_abnormal_skin_development | 1.08140682 |
| 73 | MP0008877_abnormal_DNA_methylation | 1.07114963 |
| 74 | MP0001346_abnormal_lacrimal_gland | 1.07036692 |
| 75 | MP0004924_abnormal_behavior | 1.06975347 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.06975347 |
| 77 | MP0002066_abnormal_motor_capabilities/c | 1.06590127 |
| 78 | * MP0000955_abnormal_spinal_cord | 1.04993670 |
| 79 | MP0000427_abnormal_hair_cycle | 1.04717936 |
| 80 | MP0009379_abnormal_foot_pigmentation | 1.02176472 |
| 81 | MP0005409_darkened_coat_color | 0.99994678 |
| 82 | MP0003879_abnormal_hair_cell | 0.99562565 |
| 83 | MP0002090_abnormal_vision | 0.99440990 |
| 84 | MP0002152_abnormal_brain_morphology | 0.96813053 |
| 85 | MP0003283_abnormal_digestive_organ | 0.96575027 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 0.95431442 |
| 87 | MP0001984_abnormal_olfaction | 0.95383717 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 0.94865915 |
| 89 | MP0000639_abnormal_adrenal_gland | 0.94259218 |
| 90 | MP0001944_abnormal_pancreas_morphology | 0.94158982 |
| 91 | MP0005423_abnormal_somatic_nervous | 0.94033149 |
| 92 | MP0005171_absent_coat_pigmentation | 0.92378296 |
| 93 | MP0003091_abnormal_cell_migration | 0.91323375 |
| 94 | MP0005187_abnormal_penis_morphology | 0.91060586 |
| 95 | MP0008569_lethality_at_weaning | 0.90629227 |
| 96 | MP0003122_maternal_imprinting | 0.90607072 |
| 97 | MP0005499_abnormal_olfactory_system | 0.89437345 |
| 98 | MP0005394_taste/olfaction_phenotype | 0.89437345 |
| 99 | MP0000678_abnormal_parathyroid_gland | 0.85736545 |
| 100 | MP0000538_abnormal_urinary_bladder | 0.85081837 |
| 101 | MP0004215_abnormal_myocardial_fiber | 0.84990352 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.83628506 |
| 103 | MP0001664_abnormal_digestion | 0.83602736 |
| 104 | MP0008058_abnormal_DNA_repair | 0.83583974 |
| 105 | MP0004085_abnormal_heartbeat | 0.83405944 |
| 106 | MP0003936_abnormal_reproductive_system | 0.82709796 |
| 107 | MP0003938_abnormal_ear_development | 0.82605471 |
| 108 | MP0003385_abnormal_body_wall | 0.82018032 |
| 109 | MP0005367_renal/urinary_system_phenotyp | 0.81874280 |
| 110 | MP0000516_abnormal_urinary_system | 0.81874280 |
| 111 | MP0000534_abnormal_ureter_morphology | 0.79872703 |
| 112 | MP0001963_abnormal_hearing_physiology | 0.79755374 |
| 113 | MP0004742_abnormal_vestibular_system | 0.79196641 |
| 114 | MP0003631_nervous_system_phenotype | 0.78912004 |
| 115 | MP0000428_abnormal_craniofacial_morphol | 0.78529590 |
| 116 | MP0009697_abnormal_copulation | 0.78522276 |
| 117 | MP0003632_abnormal_nervous_system | 0.76164766 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.75945487 |
| 119 | MP0000026_abnormal_inner_ear | 0.75715356 |
| 120 | MP0002254_reproductive_system_inflammat | 0.74880079 |
| 121 | MP0003633_abnormal_nervous_system | 0.74784137 |
| 122 | MP0002132_abnormal_respiratory_system | 0.74554083 |
| 123 | MP0003755_abnormal_palate_morphology | 0.74504009 |
| 124 | MP0001905_abnormal_dopamine_level | 0.74312874 |
| 125 | MP0002233_abnormal_nose_morphology | 0.73521568 |
| 126 | MP0010329_abnormal_lipoprotein_level | 0.72785533 |
| 127 | MP0004145_abnormal_muscle_electrophysio | 0.72773731 |
| 128 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72089357 |
| 129 | MP0001756_abnormal_urination | 0.71861323 |
| 130 | MP0006292_abnormal_olfactory_placode | 0.71801398 |
| 131 | MP0008057_abnormal_DNA_replication | 0.71627189 |
| 132 | MP0003786_premature_aging | 0.71457464 |
| 133 | * MP0002752_abnormal_somatic_nervous | 0.70414673 |
| 134 | MP0003861_abnormal_nervous_system | 0.70400622 |
| 135 | MP0000762_abnormal_tongue_morphology | 0.69815386 |
| 136 | MP0001958_emphysema | 0.69273619 |
| 137 | MP0002751_abnormal_autonomic_nervous | 0.69177711 |
| 138 | MP0004510_myositis | 0.69026842 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.68794192 |
| 140 | MP0002133_abnormal_respiratory_system | 0.68784344 |
| 141 | MP0005388_respiratory_system_phenotype | 0.68784344 |
| 142 | MP0001943_abnormal_respiration | 0.68485172 |
| 143 | MP0003119_abnormal_digestive_system | 0.68353618 |
| 144 | MP0002295_abnormal_pulmonary_circulatio | 0.68352289 |
| 145 | MP0000613_abnormal_salivary_gland | 0.68342806 |
| 146 | MP0005646_abnormal_pituitary_gland | 0.67484941 |
| 147 | MP0000470_abnormal_stomach_morphology | 0.66975063 |
| 148 | MP0003937_abnormal_limbs/digits/tail_de | 0.66686781 |
| 149 | MP0008789_abnormal_olfactory_epithelium | 0.65841946 |
| 150 | MP0005595_abnormal_vascular_smooth | 0.65464538 |
| 151 | MP0010678_abnormal_skin_adnexa | 0.65011815 |
| 152 | MP0001485_abnormal_pinna_reflex | 0.63120658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.08092065 |
| 2 | Atonic seizures (HP:0010819) | 5.24661368 |
| 3 | Focal seizures (HP:0007359) | 4.83865211 |
| 4 | Abdominal situs inversus (HP:0003363) | 4.66681995 |
| 5 | Abnormality of abdominal situs (HP:0011620) | 4.66681995 |
| 6 | Febrile seizures (HP:0002373) | 4.63279390 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.06887807 |
| 8 | Absence seizures (HP:0002121) | 3.99211028 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.94776989 |
| 10 | Hyperventilation (HP:0002883) | 3.69121306 |
| 11 | Myokymia (HP:0002411) | 3.61383383 |
| 12 | Dialeptic seizures (HP:0011146) | 3.57052720 |
| 13 | Visual hallucinations (HP:0002367) | 3.49204047 |
| 14 | Bifid tongue (HP:0010297) | 3.34036637 |
| 15 | Fetal akinesia sequence (HP:0001989) | 3.30847043 |
| 16 | Broad-based gait (HP:0002136) | 3.09500818 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.08595890 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.06764130 |
| 19 | Neurofibrillary tangles (HP:0002185) | 2.93753400 |
| 20 | Inability to walk (HP:0002540) | 2.90984786 |
| 21 | Absent speech (HP:0001344) | 2.90190702 |
| 22 | Anterior segment dysgenesis (HP:0007700) | 2.89811628 |
| 23 | Hydroureter (HP:0000072) | 2.89522392 |
| 24 | Type II lissencephaly (HP:0007260) | 2.86870666 |
| 25 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.86736261 |
| 26 | Transposition of the great arteries (HP:0001669) | 2.86736261 |
| 27 | Abnormal connection of the cardiac segments (HP:0011545) | 2.86736261 |
| 28 | Amblyopia (HP:0000646) | 2.85905637 |
| 29 | Excessive salivation (HP:0003781) | 2.72959285 |
| 30 | Drooling (HP:0002307) | 2.72959285 |
| 31 | Medial flaring of the eyebrow (HP:0010747) | 2.67481078 |
| 32 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.66474782 |
| 33 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.65320622 |
| 34 | Abnormality of alanine metabolism (HP:0010916) | 2.65320622 |
| 35 | Hyperalaninemia (HP:0003348) | 2.65320622 |
| 36 | Action tremor (HP:0002345) | 2.64046995 |
| 37 | Abnormal pancreas size (HP:0012094) | 2.55257206 |
| 38 | Vaginal atresia (HP:0000148) | 2.53829129 |
| 39 | Pancreatic cysts (HP:0001737) | 2.53676080 |
| 40 | Gait imbalance (HP:0002141) | 2.51160558 |
| 41 | Arterial tortuosity (HP:0005116) | 2.50904304 |
| 42 | Hypothermia (HP:0002045) | 2.50414943 |
| 43 | Genital tract atresia (HP:0001827) | 2.48142685 |
| 44 | Dysdiadochokinesis (HP:0002075) | 2.47572630 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 2.46346931 |
| 46 | Zonular cataract (HP:0010920) | 2.45928276 |
| 47 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.45506453 |
| 48 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.45506453 |
| 49 | Single umbilical artery (HP:0001195) | 2.45506453 |
| 50 | Preaxial foot polydactyly (HP:0001841) | 2.44432899 |
| 51 | Supranuclear gaze palsy (HP:0000605) | 2.39933291 |
| 52 | Abnormality of midbrain morphology (HP:0002418) | 2.39656649 |
| 53 | Molar tooth sign on MRI (HP:0002419) | 2.39656649 |
| 54 | Exotropia (HP:0000577) | 2.38494260 |
| 55 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.37510300 |
| 56 | Amelogenesis imperfecta (HP:0000705) | 2.37424188 |
| 57 | Congenital primary aphakia (HP:0007707) | 2.37127460 |
| 58 | Optic nerve hypoplasia (HP:0000609) | 2.35836398 |
| 59 | Hepatoblastoma (HP:0002884) | 2.35556522 |
| 60 | Testicular atrophy (HP:0000029) | 2.32641684 |
| 61 | Limb dystonia (HP:0002451) | 2.31920477 |
| 62 | Lower limb amyotrophy (HP:0007210) | 2.30196454 |
| 63 | Choroideremia (HP:0001139) | 2.30117307 |
| 64 | Focal segmental glomerulosclerosis (HP:0000097) | 2.28367653 |
| 65 | Vascular tortuosity (HP:0004948) | 2.27694620 |
| 66 | Methylmalonic acidemia (HP:0002912) | 2.25724122 |
| 67 | Heterochromia iridis (HP:0001100) | 2.25604793 |
| 68 | Concave nail (HP:0001598) | 2.23550744 |
| 69 | Abnormality of binocular vision (HP:0011514) | 2.22990096 |
| 70 | Diplopia (HP:0000651) | 2.22990096 |
| 71 | Nephrogenic diabetes insipidus (HP:0009806) | 2.18758900 |
| 72 | Abnormality of the dental pulp (HP:0006479) | 2.17312385 |
| 73 | Dysmetria (HP:0001310) | 2.16098949 |
| 74 | Truncal ataxia (HP:0002078) | 2.14255346 |
| 75 | Abnormality of salivation (HP:0100755) | 2.12244427 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.11497453 |
| 77 | Palpebral edema (HP:0100540) | 2.09348446 |
| 78 | Rapidly progressive (HP:0003678) | 2.09123122 |
| 79 | Epileptiform EEG discharges (HP:0011182) | 2.08572302 |
| 80 | True hermaphroditism (HP:0010459) | 2.08303674 |
| 81 | Aplasia of the musculature (HP:0100854) | 2.07812325 |
| 82 | Gonadal dysgenesis (HP:0000133) | 2.07098996 |
| 83 | Abnormality of the nasal septum (HP:0000419) | 2.07026361 |
| 84 | Impaired smooth pursuit (HP:0007772) | 2.06843389 |
| 85 | * Intestinal atresia (HP:0011100) | 2.06580647 |
| 86 | Abnormality of permanent molar morphology (HP:0011071) | 2.05569639 |
| 87 | Abnormality of the dental root (HP:0006486) | 2.05569639 |
| 88 | Taurodontia (HP:0000679) | 2.05569639 |
| 89 | Widely spaced teeth (HP:0000687) | 2.04894526 |
| 90 | Septo-optic dysplasia (HP:0100842) | 2.03127800 |
| 91 | Absent/shortened dynein arms (HP:0200106) | 2.02997550 |
| 92 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.02997550 |
| 93 | Protruding tongue (HP:0010808) | 2.02916194 |
| 94 | * Double outlet right ventricle (HP:0001719) | 2.02700340 |
| 95 | * Congenital malformation of the right heart (HP:0011723) | 2.02700340 |
| 96 | Anxiety (HP:0000739) | 2.01853839 |
| 97 | Hypoplastic labia majora (HP:0000059) | 2.00668860 |
| 98 | Short middle phalanx of the 5th finger (HP:0004220) | 1.99878141 |
| 99 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.99738116 |
| 100 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99663851 |
| 101 | Pancreatic fibrosis (HP:0100732) | 1.99114057 |
| 102 | Large for gestational age (HP:0001520) | 1.97356323 |
| 103 | Facial diplegia (HP:0001349) | 1.96075292 |
| 104 | Microretrognathia (HP:0000308) | 1.95042327 |
| 105 | * Labial hypoplasia (HP:0000066) | 1.94034528 |
| 106 | Ankyloglossia (HP:0010296) | 1.93846106 |
| 107 | Termporal pattern (HP:0011008) | 1.92876416 |
| 108 | Insidious onset (HP:0003587) | 1.92876416 |
| 109 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.92246774 |
| 110 | Delusions (HP:0000746) | 1.91341372 |
| 111 | Akinesia (HP:0002304) | 1.91041846 |
| 112 | Hyperactive renin-angiotensin system (HP:0000841) | 1.90949486 |
| 113 | Abnormality of molar (HP:0011077) | 1.90673442 |
| 114 | Abnormality of molar morphology (HP:0011070) | 1.90673442 |
| 115 | Acute necrotizing encephalopathy (HP:0006965) | 1.90367981 |
| 116 | Short hallux (HP:0010109) | 1.90147138 |
| 117 | Acute encephalopathy (HP:0006846) | 1.89924956 |
| 118 | Myelomeningocele (HP:0002475) | 1.89807613 |
| 119 | Hypoplastic nipples (HP:0002557) | 1.88563166 |
| 120 | Lissencephaly (HP:0001339) | 1.88516860 |
| 121 | Retinal dysplasia (HP:0007973) | 1.88439496 |
| 122 | Aplasia involving bones of the extremities (HP:0009825) | 1.88334898 |
| 123 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.88334898 |
| 124 | Aplasia of the phalanges of the hand (HP:0009802) | 1.88334898 |
| 125 | Depression (HP:0000716) | 1.87766439 |
| 126 | Poor eye contact (HP:0000817) | 1.86999621 |
| 127 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.86956269 |
| 128 | Popliteal pterygium (HP:0009756) | 1.86938277 |
| 129 | Thickened helices (HP:0000391) | 1.86354569 |
| 130 | Abnormal ciliary motility (HP:0012262) | 1.85984674 |
| 131 | Abnormality of vitamin B metabolism (HP:0004340) | 1.85520893 |
| 132 | Hypoglycemic coma (HP:0001325) | 1.85324939 |
| 133 | Scanning speech (HP:0002168) | 1.84432150 |
| 134 | Progressive macrocephaly (HP:0004481) | 1.82662353 |
| 135 | Hemiparesis (HP:0001269) | 1.82026261 |
| 136 | Stereotypic behavior (HP:0000733) | 1.81999685 |
| 137 | Abnormality of the labia majora (HP:0012881) | 1.81281896 |
| 138 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.81089091 |
| 139 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.80742200 |
| 140 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.80045075 |
| 141 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.79990020 |
| 142 | Gastroesophageal reflux (HP:0002020) | 1.79426388 |
| 143 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.79382349 |
| 144 | Late onset (HP:0003584) | 1.79280561 |
| 145 | Nephronophthisis (HP:0000090) | 1.78748168 |
| 146 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.77450709 |
| 147 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.77348980 |
| 148 | Absent eyebrow (HP:0002223) | 1.77063243 |
| 149 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.75961849 |
| 150 | Abnormality of oral frenula (HP:0000190) | 1.75433975 |
| 151 | Resting tremor (HP:0002322) | 1.75392511 |
| 152 | Glomerulosclerosis (HP:0000096) | 1.74908896 |
| 153 | Hypoalphalipoproteinemia (HP:0003233) | 1.73665732 |
| 154 | Occipital encephalocele (HP:0002085) | 1.73460099 |
| 155 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.72975439 |
| 156 | Stage 5 chronic kidney disease (HP:0003774) | 1.72970741 |
| 157 | Blue irides (HP:0000635) | 1.72851034 |
| 158 | Attenuation of retinal blood vessels (HP:0007843) | 1.71874672 |
| 159 | Absent frontal sinuses (HP:0002688) | 1.70119119 |
| 160 | Decreased circulating renin level (HP:0003351) | 1.70069918 |
| 161 | Fragile nails (HP:0001808) | 1.69524350 |
| 162 | Tongue fasciculations (HP:0001308) | 1.68611215 |
| 163 | * Hypoplastic female external genitalia (HP:0012815) | 1.67951284 |
| 164 | Short humerus (HP:0005792) | 1.67035957 |
| 165 | Methylmalonic aciduria (HP:0012120) | 1.66982413 |
| 166 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.66090125 |
| 167 | Lower limb asymmetry (HP:0100559) | 1.65608882 |
| 168 | EEG with generalized epileptiform discharges (HP:0011198) | 1.65410982 |
| 169 | Poor coordination (HP:0002370) | 1.65277992 |
| 170 | Hypoglycemic seizures (HP:0002173) | 1.65225677 |
| 171 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.65144525 |
| 172 | Right ventricular cardiomyopathy (HP:0011663) | 1.64228619 |
| 173 | Stenosis of the external auditory canal (HP:0000402) | 1.63805503 |
| 174 | Pterygium (HP:0001059) | 1.62602632 |
| 175 | Bronchomalacia (HP:0002780) | 1.62535440 |
| 176 | Abnormality of the labia minora (HP:0012880) | 1.62386114 |
| 177 | Hyperthyroidism (HP:0000836) | 1.61915972 |
| 178 | Hyperkalemia (HP:0002153) | 1.61624782 |
| 179 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.61428332 |
| 180 | Genetic anticipation (HP:0003743) | 1.60535297 |
| 181 | Incomplete penetrance (HP:0003829) | 1.60369288 |
| 182 | Short tibia (HP:0005736) | 1.59941859 |
| 183 | Abnormal social behavior (HP:0012433) | 1.59784676 |
| 184 | Impaired social interactions (HP:0000735) | 1.59784676 |
| 185 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.59222141 |
| 186 | Nuclear cataract (HP:0100018) | 1.56542960 |
| 187 | Abnormal eating behavior (HP:0100738) | 1.54580381 |
| 188 | Complete atrioventricular canal defect (HP:0001674) | 1.54237577 |
| 189 | Buphthalmos (HP:0000557) | 1.53769700 |
| 190 | Shallow orbits (HP:0000586) | 1.53077956 |
| 191 | Hypodontia (HP:0000668) | 1.52917480 |
| 192 | Progressive sensorineural hearing impairment (HP:0000408) | 1.52443571 |
| 193 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.52120833 |
| 194 | Progressive inability to walk (HP:0002505) | 1.51547370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.85847079 |
| 2 | NTRK3 | 4.43220840 |
| 3 | RIPK4 | 3.98036312 |
| 4 | ACVR1B | 3.11939847 |
| 5 | PBK | 2.90080558 |
| 6 | CASK | 2.89577849 |
| 7 | BMPR1B | 2.82422170 |
| 8 | PLK2 | 2.76751126 |
| 9 | TRIM28 | 2.73180225 |
| 10 | MAP3K4 | 2.60650507 |
| 11 | MAP3K12 | 2.53922719 |
| 12 | MAP2K7 | 2.32004719 |
| 13 | MAP4K2 | 2.24878067 |
| 14 | WNK3 | 2.24746215 |
| 15 | GRK1 | 2.20494552 |
| 16 | MINK1 | 2.12422100 |
| 17 | PTK2B | 2.03343638 |
| 18 | PNCK | 2.00574426 |
| 19 | BMPR2 | 1.99550119 |
| 20 | EPHB2 | 1.90535113 |
| 21 | STK16 | 1.85339768 |
| 22 | FGR | 1.83147583 |
| 23 | NTRK1 | 1.80445986 |
| 24 | NME1 | 1.77246184 |
| 25 | GRK5 | 1.74717711 |
| 26 | MKNK2 | 1.69889895 |
| 27 | CAMK2B | 1.67186565 |
| 28 | PINK1 | 1.64513635 |
| 29 | FER | 1.57904614 |
| 30 | DAPK2 | 1.53817242 |
| 31 | MAP2K4 | 1.53570000 |
| 32 | DAPK1 | 1.49139961 |
| 33 | KSR1 | 1.46225406 |
| 34 | CAMK2A | 1.39971566 |
| 35 | INSRR | 1.39435342 |
| 36 | MAP3K9 | 1.35036487 |
| 37 | MAP3K2 | 1.23392908 |
| 38 | KSR2 | 1.21865201 |
| 39 | EPHA2 | 1.17917335 |
| 40 | CDK5 | 1.15569508 |
| 41 | BCR | 1.15221755 |
| 42 | PRPF4B | 1.15069628 |
| 43 | PAK6 | 1.14168746 |
| 44 | BRSK2 | 1.13088496 |
| 45 | TSSK6 | 1.11173775 |
| 46 | PRKCG | 1.06861501 |
| 47 | EIF2AK3 | 1.04086740 |
| 48 | PHKG1 | 1.04008256 |
| 49 | PHKG2 | 1.04008256 |
| 50 | LATS2 | 1.02702131 |
| 51 | SIK2 | 1.01844458 |
| 52 | WEE1 | 0.98982216 |
| 53 | DDR2 | 0.98576727 |
| 54 | PRKCE | 0.98149416 |
| 55 | AKT3 | 0.98120297 |
| 56 | TNIK | 0.98033856 |
| 57 | FES | 0.96469489 |
| 58 | PAK3 | 0.95288667 |
| 59 | MST4 | 0.94836511 |
| 60 | MOS | 0.94672854 |
| 61 | MAP2K1 | 0.94349910 |
| 62 | STK39 | 0.93117436 |
| 63 | BRD4 | 0.92793480 |
| 64 | ROCK2 | 0.92481443 |
| 65 | ADRBK2 | 0.91324177 |
| 66 | CAMK2D | 0.90079537 |
| 67 | MARK1 | 0.88669596 |
| 68 | NTRK2 | 0.88213560 |
| 69 | STK38 | 0.87339408 |
| 70 | SIK3 | 0.86363333 |
| 71 | TGFBR1 | 0.85726558 |
| 72 | PRKCI | 0.83007617 |
| 73 | OXSR1 | 0.81763425 |
| 74 | NEK1 | 0.79541936 |
| 75 | TNK2 | 0.76661224 |
| 76 | MAPK13 | 0.74419536 |
| 77 | SGK1 | 0.73940258 |
| 78 | TYRO3 | 0.72565569 |
| 79 | PTK2 | 0.72020647 |
| 80 | MKNK1 | 0.71892054 |
| 81 | CSNK1G1 | 0.70079580 |
| 82 | DMPK | 0.69558933 |
| 83 | CDK18 | 0.67982273 |
| 84 | SRPK1 | 0.67845938 |
| 85 | ARAF | 0.66826729 |
| 86 | CDK14 | 0.66648929 |
| 87 | MET | 0.65420561 |
| 88 | CAMKK1 | 0.64825205 |
| 89 | FGFR1 | 0.63624407 |
| 90 | CDK15 | 0.63211434 |
| 91 | FRK | 0.62650269 |
| 92 | MST1R | 0.62493688 |
| 93 | CAMK2G | 0.61829534 |
| 94 | PDGFRA | 0.60940480 |
| 95 | CDK19 | 0.59420395 |
| 96 | MUSK | 0.58288083 |
| 97 | RAF1 | 0.58196095 |
| 98 | MAP3K13 | 0.56848042 |
| 99 | DYRK1A | 0.56760138 |
| 100 | CDK11A | 0.55989785 |
| 101 | CSNK1G2 | 0.55024706 |
| 102 | IRAK2 | 0.54787516 |
| 103 | NLK | 0.54544409 |
| 104 | IRAK1 | 0.53336211 |
| 105 | ROCK1 | 0.52435689 |
| 106 | SGK223 | 0.48825418 |
| 107 | SGK494 | 0.48825418 |
| 108 | RET | 0.48736682 |
| 109 | OBSCN | 0.48475449 |
| 110 | PRKD3 | 0.48255846 |
| 111 | ADRBK1 | 0.47931745 |
| 112 | ERBB3 | 0.47462161 |
| 113 | LATS1 | 0.47164790 |
| 114 | BRSK1 | 0.47082820 |
| 115 | SGK2 | 0.46460443 |
| 116 | CAMK1 | 0.45042633 |
| 117 | PLK4 | 0.44751317 |
| 118 | TRPM7 | 0.44500626 |
| 119 | LIMK1 | 0.43894854 |
| 120 | CAMK1G | 0.43581179 |
| 121 | ZAK | 0.42511156 |
| 122 | PRKCQ | 0.42261681 |
| 123 | CAMKK2 | 0.41998806 |
| 124 | FYN | 0.41677456 |
| 125 | GRK7 | 0.41632863 |
| 126 | STK38L | 0.41509339 |
| 127 | MAPK10 | 0.41276249 |
| 128 | FGFR2 | 0.39184750 |
| 129 | BMX | 0.38854164 |
| 130 | PDGFRB | 0.38500742 |
| 131 | FLT3 | 0.38499888 |
| 132 | WNK4 | 0.38309367 |
| 133 | NUAK1 | 0.38063080 |
| 134 | CSNK1G3 | 0.37892731 |
| 135 | TESK1 | 0.37705156 |
| 136 | EIF2AK1 | 0.37537582 |
| 137 | MAP3K7 | 0.37059616 |
| 138 | NEK6 | 0.36056781 |
| 139 | GRK6 | 0.35955143 |
| 140 | PRKG1 | 0.35863935 |
| 141 | PDK2 | 0.35040385 |
| 142 | PRKACA | 0.34626678 |
| 143 | MYLK | 0.34453269 |
| 144 | SRC | 0.34083445 |
| 145 | PLK3 | 0.33463530 |
| 146 | PLK1 | 0.32126196 |
| 147 | PRKCA | 0.31955294 |
| 148 | CSNK1A1 | 0.31944198 |
| 149 | MAPKAPK5 | 0.31727322 |
| 150 | ERBB4 | 0.31239564 |
| 151 | VRK1 | 0.29721363 |
| 152 | PRKACB | 0.29010858 |
| 153 | SGK3 | 0.27850129 |
| 154 | PKN2 | 0.25426850 |
| 155 | EIF2AK2 | 0.25194934 |
| 156 | CSNK1D | 0.22517075 |
| 157 | CSNK1E | 0.19517071 |
| 158 | CSNK1A1L | 0.19256229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.94289020 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.52327191 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.84262890 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.61408636 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.48794641 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45055330 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.43015516 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.42354554 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.38377878 |
| 10 | Salivary secretion_Homo sapiens_hsa04970 | 2.27565400 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21201331 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.16970641 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.14406114 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.11827917 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 2.11804967 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.10367861 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 2.10083413 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 2.07062401 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.02184735 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.99454032 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.97648665 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91676673 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85931144 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.83971100 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.82918863 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.77772009 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.75707939 |
| 28 | * Axon guidance_Homo sapiens_hsa04360 | 1.74697159 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73804488 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72656371 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71435947 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69435315 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.67533268 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.66452013 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55825739 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.52886871 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.51506772 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51170500 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.48247049 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.47723979 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.44345430 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41934383 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.41581413 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40784087 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.40470866 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.38774031 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.38284900 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.37995144 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 1.37436339 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.35065129 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30871394 |
| 52 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29308958 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.28651095 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 1.27095618 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24692828 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24427357 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23224363 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 1.22160296 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21958888 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21031985 |
| 61 | Glioma_Homo sapiens_hsa05214 | 1.17316264 |
| 62 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.16471987 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.15365438 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.14411168 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14247551 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12478374 |
| 67 | Cocaine addiction_Homo sapiens_hsa05030 | 1.12447900 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11773378 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10289112 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08970680 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07176926 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.06330592 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.05790543 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.05627688 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05252257 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05217476 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.99972126 |
| 78 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99767756 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.98260487 |
| 80 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.97862902 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96218135 |
| 82 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96121016 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94849285 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94128728 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.94065499 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93143351 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.92987720 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92847242 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92594836 |
| 90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.92142240 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91934785 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.90541995 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89122853 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.87582053 |
| 95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87501163 |
| 96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.84323522 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83681677 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.83596582 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81877384 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81806692 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81399923 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80085168 |
| 103 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.79527583 |
| 104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.78268040 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76257929 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.76118061 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75931365 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75844753 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.75516276 |
| 110 | Tight junction_Homo sapiens_hsa04530 | 0.74686392 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73355910 |
| 112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72140583 |
| 113 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.71203096 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71170887 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70547200 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70116996 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.69834416 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69790296 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68730607 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68684945 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68121586 |
| 122 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67935608 |
| 123 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66241624 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.66106394 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65133312 |
| 126 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.64473267 |
| 127 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63794630 |
| 128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63488636 |
| 129 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62838581 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.60338844 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59806234 |
| 132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59804333 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58398822 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56861939 |
| 135 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56447458 |
| 136 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.56388698 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.55879372 |
| 138 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53640751 |
| 139 | Melanoma_Homo sapiens_hsa05218 | 0.53007379 |
| 140 | RNA polymerase_Homo sapiens_hsa03020 | 0.52797579 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51656273 |
| 142 | Salmonella infection_Homo sapiens_hsa05132 | 0.50889950 |
| 143 | Phagosome_Homo sapiens_hsa04145 | 0.50330456 |
| 144 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50308584 |
| 145 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.48919476 |
| 146 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48566507 |
| 147 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48493350 |
| 148 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48259803 |
| 149 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47860682 |
| 150 | Mismatch repair_Homo sapiens_hsa03430 | 0.47070302 |
| 151 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46531981 |
| 152 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46285813 |
| 153 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.46222598 |
| 154 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45820989 |
| 155 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45760144 |
| 156 | Purine metabolism_Homo sapiens_hsa00230 | 0.44787162 |
| 157 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44246702 |
| 158 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44219910 |
| 159 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44195312 |
| 160 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43592047 |
| 161 | Platelet activation_Homo sapiens_hsa04611 | 0.39685094 |
| 162 | Shigellosis_Homo sapiens_hsa05131 | 0.38243488 |
| 163 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37464720 |
| 164 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36705704 |
| 165 | Endocytosis_Homo sapiens_hsa04144 | 0.36228263 |
| 166 | Bladder cancer_Homo sapiens_hsa05219 | 0.35846203 |

